Publications by authors named "Hiroyuki Hozawa"
Article Synopsis
- Pyoderma gangrenosum (PG) is a severe skin condition that mainly causes deep ulcers in the legs, and adalimumab is the first approved treatment for it in Japan.
- A study involving 67 patients assessed the safety and effectiveness of adalimumab, finding that most patients were older and had other health issues; 18.9% experienced adverse reactions.
- After 12 weeks, around 42.9% of patients showed significant improvement in their condition, suggesting adalimumab is generally well tolerated, but further research is needed for long-term insights.
Prescription doses of levodopa in patients with advanced Parkinson's disease (PD) are generally lower in Japan than in the United States or Europe, although Japanese guidelines for the management of PD recommend increasing the dosage as the disease progresses. However, data regarding levodopa prescription practices in patients with advanced PD in the clinical setting are limited. This retrospective observational study analyzed patterns of drug use for patients with advanced PD in Japan using claims data from hospitalized patients in the Medical Data Vision Co.
View Article and Find Full Text PDF